Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Shares of the company ended nearly 4% higher at Rs 2920 on Thursday ahead of the results. Market cap of the firm rose to Rs ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session higher. Nifty 50 closed at 23,205.35, while Sensex ended at 76,520.38. Overnight, Wall Street indices ended higher. Asian ...

Coforge’s strong performance in Q3 and solid TCV set up the base perfectly for 20 per cent-plus YoY growth in FY26, Nuvama said. Besides, margin expansion on lower ESOP costs should yield 25 per ...

Zuga Matt, the Chief Financial Officer and Chief Business Officer of Acumen Pharmaceuticals , Inc. (NASDAQ:ABOS), reported selling shares worth a total of $56,619, according to a recent SEC filing.

Revenue from operations for the December quarter was Rs 8,359 crore, marking a 16% increase from Rs 7,215 crore in the same quarter of the previous financial year.

Shares of firms like ICICI Bank, IndiGo, NTPC, UltraTech, Adani Wilmar, and others will be in focus on Friday's trade ...

IndiGo’s net profit is expected to fall 34% to ₹1,974 crore in Q3FY25 from ₹2,998.1 crore YoY. The company posted a net loss of ₹986.7 crore in the previous quarter.

YES Bank is set to announce its unaudited standalone and consolidated results for quarter and nine months ended on December ...